We welcome Achim Müller and Henrik Nilsson to the Acarix Team

We are very happy to announce and welcome our two new colleagues, Henrik Nilsson and Achim Müller to the Acarix team.

Henrik Nilsson is our new Sales Director for the Nordic Region, beginning February 25th and will take the overall responsibility for the Nordic markets and develop our business in Sweden, Finland, Norway and Denmark.

Achim Müller joined us on March 2nd as Sales Manager, Germany and will help us strengthen our presence and continues development of the DACH region, reporting to Jörg Domes, Sales Director, DACH.

Having these additional great resources in place supporting both the Nordic and German market is very well aligned with our strategic focus areas as communicated over the last quarter. Both Henrik and Achim represents the experience and skills needed in order to continue our efforts in both market and commercial development. 


Please join us in welcoming Achim and Henrik to Acarix!



Achim Müller, Sales Manager, Germany 

I am 51 years old, married and have 2 sons aged 19 and 21.
I have gained my medical knowledge from 15 years at the Ulm University Clinic and at the Alb Fils Clinic in Göppingen. As HCP, I spent most of the years within the field of anesthesia and intensive care, with a key focus on practical guidance and training of colleagues.

I have also gained experiences from the field, working within sales and application at Argon Medical, MAQUET / GETINGE and Merit Medical.

In my spare time I am a singer of the Southern rock band "Rattlesnake" and like to be out in the nature with my dog.

I'm really looking forward to working with the Acarix team and a very innovative product!



Henrik Nilsson, Sales Director, Nordic 

I´m 41-year-old and live in Southern Sweden with my family, wife, 2 daughters and a little dog.  Over the last 20 years I have gained a broad experience from the MedTech industry from various roles within sales and marketing.  I have always been working within the Cardiology field for companies like AstraZeneca, Medtronic and Abbott. Cardiology is an area I find utterly interesting and I have always appreciate being a part of the development of new therapies and solutions that can help patients live longer and better lives.

My spare time I like to spend with my family or spend a day on the golf course together with good friends.

I´m honored to be part of the experienced Acarix team and I am looking forward to establishing the CADScor®System on the Nordic market as a first line rule out device for Coronary Artery Disease.

About Acarix
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor system calculates a patient-specific CAD-score non-invasively in less than10 minutes and can help rule out more than one third of patients with at least 96% certainty of not being sick (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, certifiedadviser@redeye.se) is Certified Advisor of Acarix.

For more information, please visit www.acarix.com.